Detalhe da pesquisa
1.
Absence of Bsep/Abcb11 attenuates MCD diet-induced hepatic steatosis but aggravates inflammation in mice.
Liver Int
; 40(6): 1366-1377, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32141703
2.
Nor-Ursodeoxycholic Acid as a Novel Therapeutic Approach for Cholestatic and Metabolic Liver Diseases.
Dig Dis
; 35(3): 288-292, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28249255
3.
Therapeutic Mechanisms of Bile Acids and Nor-Ursodeoxycholic Acid in Non-Alcoholic Fatty Liver Disease.
Dig Dis
; 35(3): 282-287, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28249257
4.
Potential of nor-Ursodeoxycholic Acid in Cholestatic and Metabolic Disorders.
Dig Dis
; 33(3): 433-9, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26045280
5.
24-Norursodeoxycholic acid ameliorates experimental alcohol-related liver disease and activates hepatic PPARγ.
JHEP Rep
; 5(11): 100872, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37818230